Search Results

13 Results for "ogeda".

Sort By

Business

EGLE Therapeutics Strengthens its Board of Directors with the Appointment of Michel Detheux, Ph.D., as Independent Chairman Board Member, and with the Appointment of Mojgan Hossein-Nia, Ph.D. as Board Member Representative of Takeda Ventures

September 12, 2024
·
3 min read
Deals

Astellas Completes Acquisition Of Ogeda

May 17, 2017
·
2 min read
Ogeda Announces Fezolinetant As INN And Issuance Of U.S. Patent For ESN364

December 20, 2016
·
2 min read
Euroscreen S.A. Announces Name Change To Ogeda And Completion Of Series B Financing

October 19, 2016
·
2 min read
Drug Development

Ogeda Announces Positive Data From Phase IIa Trial Of Fezolinetant (ESN364) In The Treatment Of Menopausal Hot Flashes

January 4, 2017
·
4 min read
Drug Development

Astellas Touts Phase III Data for Menopause Drug, Eyes European Reimbursement

The company is hoping the topline results for Veozah, which won FDA approval in May, will support health technology assessments for reimbursement negotiations in Europe.

December 1, 2023
·
2 min read
·
Tyler Patchen
Deals

Astellas Takes Out Belgium Biotech in Deal Worth $853 Million

April 3, 2017
·
2 min read
Job Trends

Japanese Pharma Giant Astellas Sets Up Shop in Cambridge

July 25, 2017
·
2 min read
Business

Astellas Reports Full Year FY2016 Financial Results

April 27, 2017
·
11 min read
Drug Development

Astellas Pushes Outside of Oncology, Releases Positive Results in Anemia Trials

Tokyo-based Astellas Pharma announced that its roxadustat met its primary endpoints in the Phase III ALPS clinical trial in chronic kidney disease (CKD) patients with anemia not on dialysis. The focus of the drug is on anemia.

September 21, 2018
·
2 min read
·
Mark Terry